Albumin determined by bromocresol green leads to erroneous results in routine evaluation of patients with chronic kidney disease

Abstract

Our study shows that BCP is fit for the intended use to measure plasma albumin levels in CKD patients from all stages, including patients on hemodialysis. In contrast, most BCG-based platforms falsely overestimate the plasma albumin concentration.